Presa M, Pérez-Ruiz F, Oyagüez I 2nd line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients Clin. Rheumatol 2019. doi: 10.1007/s10067-019-04739-3 MÁS INFORMACIÓN